Hikma Pharmaceuticals announces $1bn investment to expand U.S. manufacturing

In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA has announced it will invest $1bn by 2030 to further expand its US manufacturing and R&D capabilities.   This new phase of investment – America Leans on Hikma: Quality Medicines Manufactured in the USA – will further expand Hikma’s…